Rockwell Medical, Inc.
RMTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $43 | $29 | $39 | $67 |
| - Cash | $14 | $12 | $11 | $16 |
| + Debt | $11 | $14 | $13 | $14 |
| Enterprise Value | $41 | $31 | $40 | $65 |
| Revenue | $16 | $16 | $19 | $25 |
| % Growth | -0.9% | -15% | -23.3% | – |
| Gross Profit | $2 | $3 | $3 | $4 |
| % Margin | 14.3% | 15.6% | 16.1% | 14.7% |
| EBITDA | -$1 | -$1 | -$1 | $0 |
| % Margin | -8.8% | -4.1% | -3.7% | 0.3% |
| Net Income | -$2 | -$1 | -$2 | -$1 |
| % Margin | -11% | -9.3% | -8% | -3.1% |
| EPS Diluted | -0.05 | -0.044 | -0.044 | -0.023 |
| % Growth | -14.9% | 2% | -93% | – |
| Operating Cash Flow | -$1 | $2 | -$3 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | $2 | -$4 | $0 |